21 IND AS 37 PROVISIONS CONTINGENT LIABILITIES AND CONTINGENT ASSETS : Provision is
recognised when the Company has a present obligation as a result of past events and it is
probable that an outflow of resources will be required to settle the obligation in respect of which
a reliable estimate can be made. Provisions (excluding retirement benefits) are not discounted
to their present value and are determined based on the best estimate required to settle the
obligation at the Balance Sheet date. These are reviewed at each Balance Sheet date and
adjusted to reflect the current best estimates.
22 IND AS 8 ACCOUNTING POLICIES , CHANGES IN ACCOUNTING ESTIMATES AND ERRORS : The
preparation of financial statements requires, estimates and assumptions to be made that affect
the application of accounting policies and the reported amounts of assets and liabilities and
disclosure of contingent liabilities at the date of the financial statements and the reported
amounts of revenues and expenses during the reporting period. Actual results may differ from
these estimates. Estimates and underlying assumptions are reviewed at each Balance Sheet
date. Revisions in the estimates are recognized in the periods in which the results are
known/materialize.
23 IND AS 33 EARNINGS PER SHARE (EPS):
24 IND AS 21 EFFECTS OF CHANGES IN FOREIGN EXCHANGE RATES : Foreign currency transactions
are accounted for at the rates prevailing on the date of transaction. Difference arising out of foreign
exchange rates is dealt with in the Profit & Loss account. Current assets and current liabilities relating
to foreign currency transactions remaining unsettled at the end of the year are translated at the closing
rates and profit or loss arising there from, if any, is dealt with in the Profit & Loss account.
25 MANAGEMENT REMUNERATION :
Disclosures with respect to the remuneration of directors and employees as required under section 197
of Companies Act, 2013 and Rule 5(1) Companies (Appointment and Remuneration of Managerial
Perssonel ) Rules, 2014 has been provided in the following table :
2. Balance with Parties are subject to reconciliation / confirmation with / by them. In absence of
such confirmations, balances are as per books are taken and relied upon by the auditors.
3. Payments received / made through third parties are subject to confirmation.
4. Wherever any supporting are not made available in respect of any expenses / entries, the same is relied
upon the information's and explanations given by the management to the auditors.
5. Fixed Assets are stated as certified by the Management of the company. The Auditors neither verify
the same nor were any details as to physical verification of the same made available to the Auditors
6. Previous Year's figure has been re-grouped/re-arranged wherever necessary.
7. Company has incurred for repairs and replacement for building and machinaries on account of fire
took place in the premises of plant on 06/12/2023 are Rs.36857568. Claim of the same with insurance
company is yet pending.
8. The Company is small and Medium Sized Company (SMC) as defined in the Companies (Accounting
Standard) Rules, 2021 notified under the Companies Act, 2013. Accordingly, the company has complied
with the Accounting Standard as applicable to a Small and Medium Sized Company.
Other Disclosures :
(A) Disclosures required under Section 22 of the Micro, Small and Medium Enterprises Development
Act,2006
The company is in the process of obtaining information regarding enterprises covered under Micro, Small
and Medium Enterprises as per MSMED Act,2006. Details of Micro, Small to the extent available are
recorded.The Company has not made any payment of Interest nor provided Interest payable if any on
dues to suppliers.
For B A Shah S R Mehta & Co. For PARMAX PHARMA LIMITED
Chartered Accountants
Firm Registration No : 128796W
Managing
Malay Shah Director Director
Partner (Umang Gosalia) (Nikhil S Uchat)
Membership No. : 159526 DIN : 05153830 DIN : 08427983
UDIN: 25159526BMNYUT2682
Chief Financial
Place: Rajkot Officer Company Secretary
Date: 30.05.2025 (Keyur Vora) (Bhakti R Aghera)
| 